Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengting Yan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Research Communications|August 5, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid TumorsFunda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and DexamethasoneJames P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.
Blood|January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphomaLapo Alinari, Bo Yu, Beth A Christian, et al.
Nature Medicine|June 24, 2024
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Nature Medicine|June 1, 2024
Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Blood|March 7, 2015
Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformationLapo Alinari, Kiran V Mahasenan, Fengting Yan, et al.
Cancer Research|January 24, 2014
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastomaFengting Yan, Lapo Alinari, Mark E Lustberg, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Research Communications|August 5, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid TumorsFunda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and DexamethasoneJames P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.
Blood|January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphomaLapo Alinari, Bo Yu, Beth A Christian, et al.
Nature Medicine|June 24, 2024
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Nature Medicine|June 1, 2024
Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Blood|March 7, 2015
Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformationLapo Alinari, Kiran V Mahasenan, Fengting Yan, et al.
Cancer Research|January 24, 2014
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastomaFengting Yan, Lapo Alinari, Mark E Lustberg, et al.
Pageof 3